Roche Diagnostics CEO leaving to join Arizona company
Jack Phillips, who has led Roche Diagnostics’ North American operations in Indianapolis since 2010, will become chief operating officer of Accelerate Diagnostics in Tucson.
Life Science & Biotech
Articles
Community Health Network HQ gets new property owner, plans to expand office space
An Indianapolis-based real estate company that specializes in health care properties has acquired more than 300,000 square feet of commercial office space on the city’s northeast side, including the headquarters of Community Health Network.
Boom in Medicare business fueling eHealth’s growth, expansion into Indianapolis
The company has been bleeding red ink, but its Medicare business is booming and could ring up nearly $100 million in profit this year—if the company can hire enough people to help all the seniors calling in with questions.
Want to buy a tobacco-cessation product in Indiana? No prescription needed anymore
The goal is to make the products more affordable and accessible—and to reduce Indiana’s high smoking rate. More than 1.1 million adult Hoosiers smoke, and Indiana ranks 44th among states in smoking rate.
BioCrossroads chooses retired Lilly exec as new CEO
Patricia Martin, 58, former chief operating officer of Lilly’s diabetes division, will start her new job July 1, leading an organization that promotes and invests in the state’s life sciences sector.
Corteva keeps local workforce but growth plans aren’t crystal clear
DowDuPont this month spun off the agricultural chemicals, seeds and plant biotechnology firm, turning it into a standalone public company.
Butler plans $100M renovation, expansion of science facilities
The school said the three-phase project will include construction and renovation of 96,000 square feet of buildings to create a science complex featuring “high-tech classrooms, modern research labs, and collaborative working spaces.”
DowDuPont CEO stresses long-term outlook as company splits into three
Hundreds of employees at the Corteva Agriscience Global Business Center in Indianapolis on Monday celebrated the official launch of the company and the first trading of its common stock.
Drug research firm Covance plans $17.5M expansion, 203 jobs
Plans call for the company to spend $11.8 million on the real estate improvements and another $5.7 million on new IT equipment and freezers.
Bioanalytical Systems buys toxicology firm
Bioanalytical Systems said May 1 it purchased Smithers Avanza Toxicology Services in suburban Washington, D.C.
Recently launched research institute pursuing life science innovations through ‘team science’
Backed by more than $100 million in funding from Indiana companies and foundations, the Indiana Biosciences Research Institute has hired 39 employees and hopes to ramp up to 80 within another three years.
Life science companies can learn from failure if they stay flexible, experts say
Endocyte Inc.'s decision two years ago to shelve its own pipeline and look for other opportunities was a difficult call that eventually paid off for investors, its former CEO said Friday at IBJ’s Life Sciences Power Breakfast.
Elanco agrees to buy pet-drug developer for $234 million
Kansas-based Aratana Therapeutics has three treatments approved by the U.S. Food and Drug Administration and is working on drugs for a range of disease fields, including cancer.
Fast BioMedical achieves clinical endpoints with plasma technology
The Carmel startup said its midstage clinical trials met key objectives, an achievement that will it allow to continue developing a technology that measures blood volume and kidney function.
Lilly’s $7M tax-abatement request advanced by City-County Council panel
The proposed tax abatement is related to a $91 million investment the company is making in a building at the Lilly Technology Center on Kentucky Avenue.
Indiana’s life sciences sector growing in jobs, wages, companies
A new study by BioCrossroads and Indiana University shows the sector’s economic impact grew about 1 percent last year, to $79 billion.
Lilly to introduce generic version of insulin at half off Humalog’s list price
The move comes at a time drug makers, especially those that make insulin, are facing withering criticism for raising prices.
Roche makes $4.8 billion acquisition bid for gene-therapy company
Spark Therapeutics Inc. will give Roche Holding a chance to make up ground in a field where single treatments may command more than $1 million. It also snaps up an asset that rivals like Novartis might have coveted.
Venture firm invests $8.3M in local startup with fat-replacement product
Indianapolis-based Epogee LLC has developed a fat substitute to reduce the calories in sweets and other comfort foods. The new investment will allow the firm to scale up.